Advisory Council for the Elimination of Tuberculosis Meeting (ACET), 57438 [2019-23237]

Download as PDF 57438 Federal Register / Vol. 84, No. 207 / Friday, October 25, 2019 / Notices departments will also expand the SUDORS case definition beyond the current focus on opioid-related overdose deaths to include all individuals who died of an unintentional or undetermined intent drug-related overdose. The expanded focus will allow CDC and health departments to begin characterizing overdose deaths attributable to emerging illicit drug threats (e.g., non-opioid synthetic drugs), deaths attributable to opioid couse with other classes of drugs (e.g., gabapentin or benzodiazapine), and the extent to which certain types of prescription drugs (both opioid and non-opioid) are involved in fatal overdoses. Participating states and jurisdictions will continue to report SUDORS information to CDC through a module in the NVDRS web-based platform. Stateand jurisdiction-level public health departments will be funded to abstract standardized data elements from ME/C reports as well as death certificates. Beginning in 2020, cooperative agreement goals include reducing the time lag for reporting from eight months to no more than six months. Information can be entered into the SUDORS system at any time, but reports on overdose deaths that occur between January 1 and June 30 will be entered into the SUDORS by December of the same calendar year. Data entry for overdose deaths that occur between July 1 and December 31 will be complete by June of the next calendar year. The accelerated reporting schedule is needed to support timely identification of the causes of overdose deaths, and effective public health intervention. This Revision request does not entail a change in the estimated burden per response, which is based on the time needed for a health department to retrieve and refile vital statistics records, ME/C records, etc. The estimated burden per response does not include the time needed to abstract SUDORS data variables from those sources, since this activity is funded by the SUDORS cooperative agreement. Total estimated annualized burden will increase due to the inclusion of additional types of overdose-related deaths. Also, increased Congressional appropriation in 2019 to expand SUDORS nationwide as a component of CDC’s Overdose Data to Action (OD2A) Notice of Funding Opportunity (NOFO) (CDC–RFA–CE19–1904, posted February 1, 2019) requires expanding the number of participating jurisdictions from 50 to 52. OMB approval is requested for three years. The total estimated annualized burden hours are 32,838. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Form name Public Agencies .............................................. Retrieving and refiling records ....................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2019–23367 Filed 10–24–19; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis Meeting (ACET) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Council for the Elimination of Tuberculosis Meeting (ACET). This meeting is open to the public, limited to 80 room seats and 100 ports for audio phone lines. Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt is SUMMARY: VerDate Sep<11>2014 18:04 Oct 24, 2019 Jkt 250001 Monday, December 9, 2019. Persons who desire to make an oral statement, may request it at the time of the public comment period on December 11, 2019 at 11:40 a.m., EST. DATES: The meeting will be held on December 10, 2019, 8:30 a.m. to 4:30 p.m., EST and December 11, 2018, 8:30 a.m. to 12:00 p.m., EST. ADDRESSES: CDC, 8 Corporate Boulevard, Building 8, Conference Rooms 1–A/B/C, Atlanta, Georgia 30329–4027 and Web conference: 1– 877–927–1433 and participant passcode: 12016435 and https:// adobeconnect.cdc.gov/r5p8l2tytpq/. FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E–07, Atlanta, Georgia 30329–4027, telephone (404) 639–8317; zkr7@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This Council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and PO 00000 Frm 00057 Fmt 4703 Sfmt 9990 Total number of responses per respondent 52 1,263 Average burden per response (in hours) 30/60 reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Considered: The agenda will include discussions on (1) Use of Project ECHO in supporting tuberculosis (TB) activities; (2) Update on CDC Centers of Excellence for TB Training, Education and Medical Consultation; (3) Update on Latent Tuberculosis Infection (LTBI) communications campaign; (4) TB Host Directed Therapy; and (5) Updates from ACET workgroups. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–23237 Filed 10–24–19; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\25OCN1.SGM 25OCN1

Agencies

[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Page 57438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23237]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis Meeting 
(ACET)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Council for the 
Elimination of Tuberculosis Meeting (ACET). This meeting is open to the 
public, limited to 80 room seats and 100 ports for audio phone lines. 
Time will be available for public comment. The public is welcome to 
submit written comments in advance of the meeting. Comments should be 
submitted in writing by email to the contact person listed below. The 
deadline for receipt is Monday, December 9, 2019. Persons who desire to 
make an oral statement, may request it at the time of the public 
comment period on December 11, 2019 at 11:40 a.m., EST.

DATES: The meeting will be held on December 10, 2019, 8:30 a.m. to 4:30 
p.m., EST and December 11, 2018, 8:30 a.m. to 12:00 p.m., EST.

ADDRESSES: CDC, 8 Corporate Boulevard, Building 8, Conference Rooms 1-
A/B/C, Atlanta, Georgia 30329-4027 and Web conference: 1-877-927-1433 
and participant passcode: 12016435 and https://adobeconnect.cdc.gov/r5p8l2tytpq/.

FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee 
Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E-07, 
Atlanta, Georgia 30329-4027, telephone (404) 639-8317; [email protected].

SUPPLEMENTARY INFORMATION:
    Purpose: This Council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations regarding 
policies, strategies, objectives, and priorities; addresses the 
development and application of new technologies; and reviews the extent 
to which progress has been made toward eliminating tuberculosis.
    Matters To Be Considered: The agenda will include discussions on 
(1) Use of Project ECHO in supporting tuberculosis (TB) activities; (2) 
Update on CDC Centers of Excellence for TB Training, Education and 
Medical Consultation; (3) Update on Latent Tuberculosis Infection 
(LTBI) communications campaign; (4) TB Host Directed Therapy; and (5) 
Updates from ACET workgroups. Agenda items are subject to change as 
priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-23237 Filed 10-24-19; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.